Approval · Notice of Compliance 2565 · 2001
VENTOLIN INHALER: Notice of Compliance 2565
Issued August 28, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2565
- Date
- August 28, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Bronchodilator (beta2-adrenergic stimulant)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VENTOLIN INHALER | 02213478 | Cancelled Post Market |
| VENTOLIN I.M. INJECTION | 02213443 | Cancelled Post Market |
| VENTOLIN I.V. INFUSION SOLUTION | 02213451 | Marketed |
| VENTOLIN I.V. BOLUS INJECTION | 02213435 | Cancelled Post Market |
| VENTOLIN ROTACAPS | 02212315 | Cancelled Post Market |
| VENTOLIN ROTACAPS | 02212323 | Cancelled Post Market |
| VENTOLIN ORAL LIQUID | 02212390 | Cancelled Post Market |
| VENTOLIN DISKUS | 02243115 | Marketed |
| VENTOLIN RESPIRATOR SOLUTION | 02213486 | Marketed |
Medicinal ingredients
- SALBUTAMOL 100 MCG per ACT
- SALBUTAMOL SULFATE 0.5 MG per ML
- SALBUTAMOL SULFATE 1 MG per ML
- SALBUTAMOL SULFATE 0.25 MG per 5ML
- SALBUTAMOL SULFATE 200 MCG per CAP
- SALBUTAMOL SULFATE 400 MCG per CAP
- SALBUTAMOL SULFATE 0.4 MG per ML
- SALBUTAMOL SULFATE 200 MCG per BLD
- SALBUTAMOL SULFATE 5 MG per ML